{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T12:41:44Z","timestamp":1790167304209,"version":"4.1.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,9]],"date-time":"2020-07-09T00:00:00Z","timestamp":1594252800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,9]],"date-time":"2020-07-09T00:00:00Z","timestamp":1594252800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Med. Toxicol."],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1007\/s13181-020-00795-3","type":"journal-article","created":{"date-parts":[[2020,7,9]],"date-time":"2020-07-09T17:07:45Z","timestamp":1594314465000},"page":"10-15","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Opioid Overdose Deaths with Buprenorphine Detected in Postmortem Toxicology: a Retrospective Analysis"],"prefix":"10.1007","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6141-1776","authenticated-orcid":false,"given":"Rachel S.","family":"Wightman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanmarie","family":"Perrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Scagos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxwell","family":"Krieger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lewis S.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon D.L.","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,9]]},"reference":[{"issue":"2","key":"795_CR1","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1093\/bja\/57.2.192","volume":"57","author":"RA Boas","year":"1985","unstructured":"Boas RA, Villiger JW. Clinical actions of fentanyl and buprenorphine. Br J Anaesth. 1985;57(2):192\u20136. https:\/\/doi.org\/10.1093\/bja\/57.2.192.","journal-title":"Br J Anaesth"},{"issue":"5","key":"795_CR2","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1093\/bja\/ael051","volume":"96","author":"A Dahan","year":"2006","unstructured":"Dahan A, Yassen A, Romberg R, Sarton E, Teppema L, Olofsen E, et al. Buprenorphine induces ceiling in respiratory depression but not in analgesia. Br J Anaesth. 2006;96(5):627\u201332. https:\/\/doi.org\/10.1093\/bja\/ael051.","journal-title":"Br J Anaesth"},{"key":"795_CR3","unstructured":"Buprenorphine Explained, And opioid addiction treatment tips. ACEP Now https:\/\/www.acepnow.com\/article\/buprenorphine-explained-and-opioid-addiction-treatment-tips\/. Accessed January 29, 2019."},{"key":"795_CR4","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.drugpo.2017.05.039","volume":"46","author":"E Kelty","year":"2017","unstructured":"Kelty E, Hulse G. Fatal and non-fatal opioid overdose in opioid dependent patients treated with methadone, buprenorphine or implant naltrexone. Int J Drug Policy. 2017;46:54\u201360. https:\/\/doi.org\/10.1016\/j.drugpo.2017.05.039.","journal-title":"Int J Drug Policy"},{"issue":"3","key":"795_CR5","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1055\/s-2006-941482","volume":"39","author":"M Soyka","year":"2006","unstructured":"Soyka M, Penning R, Wittchen U. Fatal poisoning in methadone and buprenorphine treated patients -- are there differences? Pharmacopsychiatry. 2006;39(3):85\u20137. https:\/\/doi.org\/10.1055\/s-2006-941482.","journal-title":"Pharmacopsychiatry."},{"issue":"7","key":"795_CR6","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1111\/j.1360-0443.2008.02244.x","volume":"103","author":"C Welsh","year":"2008","unstructured":"Welsh C, Sherman SG, Tobin KE. A case of heroin overdose reversed by sublingually administered buprenorphine\/naloxone (suboxone). Addict Abingdon Engl. 2008;103(7):1226\u20138. https:\/\/doi.org\/10.1111\/j.1360-0443.2008.02244.x.","journal-title":"Addict Abingdon Engl"},{"key":"795_CR7","unstructured":"Sontag D. Addiction treatment with a dark side. The New York Times. https:\/\/www.nytimes.com\/2013\/11\/17\/health\/in-demand-in-clinics-and-on-the-street-bupe-can-be-savior-or-menace.html. Published November 16, 2013. Accessed October 23, 2019."},{"key":"795_CR8","unstructured":"Opinion | Addicted to a Treatment for Addiction - The New York Times. https:\/\/www.nytimes.com\/2016\/05\/29\/opinion\/sunday\/addicted-to-a-treatment-for-addiction.html. Accessed October 23, 2019."},{"key":"795_CR9","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.forsciint.2018.08.010","volume":"291","author":"P Kriikku","year":"2018","unstructured":"Kriikku P, H\u00e4kkinen M, Ojanper\u00e4 I. High buprenorphine-related mortality is persistent in Finland. Forensic Sci Int. 2018;291:76\u201382. https:\/\/doi.org\/10.1016\/j.forsciint.2018.08.010.","journal-title":"Forensic Sci Int"},{"key":"795_CR10","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.drugalcdep.2015.08.007","volume":"155","author":"D Paone","year":"2015","unstructured":"Paone D, Tuazon E, Stajic M, Sampson B, Allen B, Mantha S, et al. Buprenorphine infrequently found in fatal overdose in New York City. Drug Alcohol Depend. 2015;155:298\u2013301. https:\/\/doi.org\/10.1016\/j.drugalcdep.2015.08.007.","journal-title":"Drug Alcohol Depend"},{"key":"795_CR11","unstructured":"TDH finds some overdose deaths associated with buprenorphine. https:\/\/www.tn.gov\/health\/news\/2018\/1\/8\/tdh-finds-some-overdose-deaths-associated-with-buprenorphine.html. Accessed September 23, 2019."},{"issue":"1\u20133","key":"795_CR12","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.forsciint.2012.03.016","volume":"220","author":"T Seld\u00e9n","year":"2012","unstructured":"Seld\u00e9n T, Ahlner J, Druid H, Kronstrand R. Toxicological and pathological findings in a series of buprenorphine related deaths. Possible risk factors for fatal outcome. Forensic Sci Int. 2012;220(1\u20133):284\u201390. https:\/\/doi.org\/10.1016\/j.forsciint.2012.03.016.","journal-title":"Forensic Sci Int"},{"issue":"1\u20133","key":"795_CR13","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.forsciint.2013.06.017","volume":"232","author":"M H\u00e4kkinen","year":"2013","unstructured":"H\u00e4kkinen M, Heikman P, Ojanper\u00e4 I. Parenteral buprenorphine-naloxone abuse is a major cause of fatal buprenorphine-related poisoning. Forensic Sci Int. 2013;232(1\u20133):11\u20135. https:\/\/doi.org\/10.1016\/j.forsciint.2013.06.017.","journal-title":"Forensic Sci Int"},{"key":"795_CR14","unstructured":"Drug Overdose Deaths: Department of Health. http:\/\/www.health.ri.gov\/data\/drugoverdoses\/. Accessed September 11, 2019."},{"issue":"8","key":"795_CR15","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1093\/jat\/32.8.586","volume":"32","author":"R Kronstrand","year":"2008","unstructured":"Kronstrand R, Nystr\u00f6m I, Andersson M, et al. Urinary detection times and metabolite\/parent compound ratios after a single dose of buprenorphine. J Anal Toxicol. 2008;32(8):586\u201393. https:\/\/doi.org\/10.1093\/jat\/32.8.586.","journal-title":"J Anal Toxicol"},{"key":"795_CR16","unstructured":"Center for Drug Evaluation and Research. FDA ANDA 022410Orig1s000 Suxobone. Page 19. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2010\/022410Orig1s000AdminCorres.pdf. Accessed (October 23, 2019)."},{"key":"795_CR17","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.forsciint.2017.12.031","volume":"284","author":"CN Chatterton","year":"2018","unstructured":"Chatterton CN, Scott-Ham M. The distribution and redistribution of fentanyl & norfentanyl in post mortem samples. Forensic Sci Int. 2018;284:146\u201352. https:\/\/doi.org\/10.1016\/j.forsciint.2017.12.031.","journal-title":"Forensic Sci Int"},{"issue":"3","key":"795_CR18","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.yrtph2010.12.007","volume":"59","author":"DA Volpe","year":"2011","unstructured":"Volpe DA, McMahon TGA, Mellon RD, et al. Uniform assessment and ranking of opioid \u03bc receptor binding constants for selected opioid drugs. Regul Toxicol Pharmacol. 2011;59(3):385\u201390. https:\/\/doi.org\/10.1016\/j.yrtph2010.12.007.","journal-title":"Regul Toxicol Pharmacol"},{"issue":"2","key":"795_CR19","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1111\/bph.12796","volume":"172","author":"TV Khroyan","year":"2015","unstructured":"Khroyan TV, Wu J, Polgar WE, Cami-Kobeci G, Fotaki N, Husbands SM, et al. BU08073 a buprenorphine analogue with partial agonist activity at \u03bc-receptors in vitro but long-lasting opioid antagonist activity in vivo in mice. Br J Pharmacol. 2015;172(2):668\u201380. https:\/\/doi.org\/10.1111\/bph.12796.","journal-title":"Br J Pharmacol"},{"issue":"2\u20133","key":"795_CR20","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.forsciint.2004.02.013","volume":"142","author":"OH Drummer","year":"2004","unstructured":"Drummer OH. Postmortem toxicology of drugs of abuse. Forensic Sci Int. 2004;142(2\u20133):101\u201313. https:\/\/doi.org\/10.1016\/j.forsciint.2004.02.013.","journal-title":"Forensic Sci Int"},{"issue":"11","key":"795_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002963","volume":"16","author":"JL Yedinak","year":"2019","unstructured":"Yedinak JL, Goedel WC, Paull K, Lebeau R, Krieger MS, Thompson C, et al. Defining a recovery-oriented cascade of care for opioid use disorder: a community-driven, statewide cross-sectional assessment. PLoS Med. 2019;16(11):e1002963. https:\/\/doi.org\/10.1371\/journal.pmed.1002963.","journal-title":"PLoS Med"},{"key":"795_CR22","unstructured":"hampson.us RIG (RI G RI Department of Health (RIDOH), Behavioral Healthcare, Developmental Disabilities and Hospitals (BHDDH), Brown University (brown edu). Medication-Assisted Treatment Data \u2013 Prevent Overdose RI. https:\/\/preventoverdoseri.org\/medication-assisted-therapy\/. Accessed October 7, 2019."},{"issue":"7","key":"795_CR23","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1111\/j.1526-4637.2010.00877.x","volume":"11","author":"N Dasgupta","year":"2010","unstructured":"Dasgupta N, Bailey EJ, Cicero T, Inciardi J, Parrino M, Rosenblum A, et al. Post-marketing surveillance of methadone and buprenorphine in the United States. Pain Med Malden Mass. 2010;11(7):1078\u201391. https:\/\/doi.org\/10.1111\/j.1526-4637.2010.00877.x.","journal-title":"Pain Med Malden Mass"},{"issue":"2","key":"795_CR24","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.jemermed.2012.11.104","volume":"45","author":"S Lee","year":"2013","unstructured":"Lee S, Klein-Schwartz W, Welsh C, Doyon S. Medical outcomes associated with nonmedical use of methadone and buprenorphine. J Emerg Med. 2013;45(2):199\u2013205. https:\/\/doi.org\/10.1016\/j.jemermed.2012.11.104.","journal-title":"J Emerg Med"}],"container-title":["Journal of Medical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13181-020-00795-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13181-020-00795-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13181-020-00795-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,9]],"date-time":"2021-07-09T00:16:00Z","timestamp":1625789760000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13181-020-00795-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,9]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["795"],"URL":"https:\/\/doi.org\/10.1007\/s13181-020-00795-3","relation":{},"ISSN":["1556-9039","1937-6995"],"issn-type":[{"value":"1556-9039","type":"print"},{"value":"1937-6995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,9]]},"assertion":[{"value":"20 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}